| 000 | 01047 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513115132.0 | ||
| 264 | 0 | _c19970514 | |
| 008 | 199705s 0 0 eng d | ||
| 022 | _a0094-0143 | ||
| 024 | 7 |
_a10.1016/s0094-0143(05)70371-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVessella, R L | |
| 245 | 0 | 0 |
_aIssues in the assessment of prostate-specific antigen immunoassays. An update. _h[electronic resource] |
| 260 |
_bThe Urologic clinics of North America _cMay 1997 |
||
| 300 |
_a261-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aEpitope Mapping |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoassay |
| 650 | 0 | 4 |
_aKallikreins _xanalysis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aTissue Kallikreins |
| 700 | 1 | _aLange, P H | |
| 773 | 0 |
_tThe Urologic clinics of North America _gvol. 24 _gno. 2 _gp. 261-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0094-0143(05)70371-2 _zAvailable from publisher's website |
| 999 |
_c9107746 _d9107746 |
||